Search

everythinglearnresearchcommunity

for

Search:↓

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Autophagy helps control skin inflammation and cancer responses and regulates hair growth by affecting stem cell activity.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

A boy with a new NR5A1 gene mutation has a sex development disorder without affecting his adrenal glands.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

The frizzy mouse and hairless rat mutations are due to changes in the Prss8 gene.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

A woman with a unique syndrome similar to TRPS has a genetic change near the TRPS1 gene, affecting its regulation.

TRF1 is crucial for creating and maintaining stem cells and marks both pluripotent and adult stem cells.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

A new engineered treatment shows promise in curing heart fibrosis.

COVID-19 can cause a temporary hair loss condition.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Hair loss can happen after a fever caused by Rickettsia conorii infection.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

The Korean study found that twenty-nail dystrophy mainly affects adults, more often women, and has five distinct types with different clinical progressions.

Fractional microneedle radiofrequency is a safe and effective skin treatment with minimal serious side effects.

COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.

Better training and awareness are needed to properly diagnose and treat tinea favosa in immigrant populations.

Anti-CD19 therapy may help treat SLE and NMOSD.

KRT14 gene variants cause dermatopathia pigmentosa reticularis, affecting nails, teeth, and hair.